SLS BIO Co., Ltd (KOSDAQ:246250)

SLS BIO Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2015	FY 2014
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2015	Dec 31, 2014
Market Capitalization	26,889	26,288	35,233	33,970	-	-
Market Cap Growth	-39.10%	-25.39%	3.72%	-	-	-
Enterprise Value	20,820	18,917	33,628	36,114	-	-
Last Close Price	1969.00	1925.00	2554.40	2462.82	-	-
PE Ratio	8141.94	78.33	24.57	12.02	-	-
PS Ratio	3.33	3.14	3.91	3.16	-	-
PB Ratio	2.18	2.10	2.62	5.07	-	-
P/TBV Ratio	2.21	2.13	2.67	5.20	-	-
P/FCF Ratio	51.74	97.39	16.30	10.25	-	-
P/OCF Ratio	15.92	15.23	10.26	8.42	-	-
EV/Sales Ratio	2.58	2.26	3.73	3.36	-	-
EV/EBITDA Ratio	15.71	11.65	14.56	9.69	-	-
EV/EBIT Ratio	-	65.77	32.62	14.90	-	-
EV/FCF Ratio	40.06	70.08	15.56	10.90	-	-
Debt / Equity Ratio	0.13	0.14	0.16	0.38	0.83	4.39
Debt / EBITDA Ratio	1.20	1.05	0.91	0.68	3.61	3.68
Debt / FCF Ratio	3.07	6.34	0.97	0.76	42.09	6.16
Asset Turnover	0.49	0.49	0.61	-	0.66	-
Inventory Turnover	28.11	28.11	20.82	-	-	-
Quick Ratio	7.85	6.45	6.57	2.73	1.24	0.60
Current Ratio	8.05	6.64	6.77	2.97	1.26	0.61
Return on Equity (ROE)	0.03%	2.58%	14.22%	-	6.63%	-
Return on Assets (ROA)	-0.04%	1.05%	4.35%	-	3.45%	-
Return on Capital (ROIC)	-0.05%	1.21%	5.20%	-	4.22%	-
Return on Capital Employed (ROCE)	-	1.90%	6.40%	25.00%	7.50%	20.80%
Earnings Yield	0.01%	1.28%	4.07%	8.32%	-	-
FCF Yield	1.93%	1.03%	6.13%	9.76%	-	-
Payout Ratio	11618.49%	114.33%	-	-	-	-
Buyback Yield / Dilution	-18.73%	-8.73%	-104.97%	-37.54%	-14.68%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.